Fabric Revolutionizes Healthcare with $60M Series A Funding

February 23, 2024, 7:27 am
Fabric
Fabric
Total raised: $60M
Fabric, a NYC-based health tech company, secured a whopping $60 million in Series A funding to propel its mission of transforming healthcare through automation and AI. Led by General Catalyst, the funding round also saw participation from Thrive Capital, GV (Google Ventures), and other key investors.

Fabric's care enablement system aims to streamline clinical and administrative tasks, empowering both patients and clinicians. By leveraging AI capabilities, the company seeks to enhance customer efficiency and explore strategic merger and acquisition opportunities.

CEO Aniq Rahman leads Fabric in providing a comprehensive care enablement system that offers solutions for in-person care, virtual care, and engagement. Through conversational AI and intelligent adaptive interviews, Fabric unifies virtual and in-person care processes, automating workflows for over 3,500 clinicians and facilitating more than 12 million patient interactions.

With the healthcare system facing challenges like clinician burnout and a projected physician shortage, Fabric's platform addresses these issues head-on. By optimizing resource allocation, increasing access to care, and improving clinical capacity, Fabric aims to humanize healthcare and make a significant impact in the industry.

The company's milestones speak volumes about its success, with over 70 leading health systems onboard, 3,500+ empowered clinicians, and 12 million+ patient interactions. The latest funding will drive team expansion, platform enhancements, and strategic acquisitions, further solidifying Fabric's position as a game-changer in the healthcare landscape.

Aniq Rahman, Fabric's founder and CEO, expressed excitement about the partnership with General Catalyst, emphasizing the company's commitment to overcoming healthcare challenges and providing seamless and intuitive care experiences. Fabric's innovative approach to healthcare automation is set to revolutionize the industry and pave the way for a more efficient and patient-centric future.